The stock dipped 7 per cent to Rs 1,016 on BSE after the company's consolidated net profit more-than-halved at Rs 67 crore in Q3FY19, due to lower sales.
from Latest News http://bit.ly/2S12Usi
Thursday, 31 January 2019
Share buyback nod fails to lift Ajanta Pharma; falls 7% on weak Q3 results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment